Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001047469-17-003691
Filing Date
2017-05-26
Accepted
2017-05-26 17:06:31
Documents
10
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a2232254z10-ka.htm 10-K/A 1756349
2 EX-23.1 a2232254zex-23_1.htm EX-23.1 3709
3 EX-31.1 a2232254zex-31_1.htm EX-31.1 8326
4 EX-31.2 a2232254zex-31_2.htm EX-31.2 8313
5 EX-32.1 a2232254zex-32_1.htm EX-32.1 4580
6 EX-32.2 a2232254zex-32_2.htm EX-32.2 4570
7 G356540.JPG g356540.jpg GRAPHIC 44538
8 G131300.JPG g131300.jpg GRAPHIC 17264
9 G956629.JPG g956629.jpg GRAPHIC 2407
10 G906790.JPG g906790.jpg GRAPHIC 21668
  Complete submission text file 0001047469-17-003691.txt   1905706
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Animal Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36714 | Film No.: 17874812
SIC: 2834 Pharmaceutical Preparations